OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE
Lingfeng Diao, Chendong Wang, Ran You, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 4, pp. 746-753
Closed Access | Times Cited: 11
Lingfeng Diao, Chendong Wang, Ran You, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 4, pp. 746-753
Closed Access | Times Cited: 11
Showing 11 citing articles:
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Jiahui Yu, Yong Li, Junsheng Yu, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 3, pp. 109573-109573
Closed Access
Jiahui Yu, Yong Li, Junsheng Yu, et al.
European Journal of Surgical Oncology (2025) Vol. 51, Iss. 3, pp. 109573-109573
Closed Access
Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study
Mingsong Wu, Zenglong Que, Shujie Lai, et al.
Cellular Oncology (2025)
Open Access
Mingsong Wu, Zenglong Que, Shujie Lai, et al.
Cellular Oncology (2025)
Open Access
Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
Lingling Zhao, Cheng Xu, Jiewen Deng, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Lingling Zhao, Cheng Xu, Jiewen Deng, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
Ying Wu, Zhimin Zeng, Shuanggang Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ying Wu, Zhimin Zeng, Shuanggang Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Value of Hepatic Artery Infusion Chemotherapy (HAIC) in the Treatment of Patients with Hepatocellular Carcinoma (HCC) Resistant to Transcatheter Arterial Chemoembolization (TACE)
鹏 蒋
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 324-330
Closed Access
鹏 蒋
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 324-330
Closed Access
Efficacy analysis of hepatic arterial infusion chemotherapy combined with sintilimab and bevacizumab for initially unresectable hepatocellular carcinoma
Zhu Chen, Xingyu Chen, Haiyang Hu, et al.
iLiver (2025), pp. 100163-100163
Open Access
Zhu Chen, Xingyu Chen, Haiyang Hu, et al.
iLiver (2025), pp. 100163-100163
Open Access
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes
Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 2, pp. 721-729
Open Access | Times Cited: 1
Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 2, pp. 721-729
Open Access | Times Cited: 1
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access | Times Cited: 1
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access | Times Cited: 1
Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies
Yusuf İlhan, Yakup Ergün
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 2888-2893
Open Access
Yusuf İlhan, Yakup Ergün
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 2888-2893
Open Access
Hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors versus lenvatinib and PD-1 inhibitors for unresectable HCC: a meta-analysis
Min Wei, P H Zhang, Chao Feng Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Min Wei, P H Zhang, Chao Feng Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
